cdmo.directory
← Compare landing

Eurofins Central Laboratory vs Genevoyager (Wuhan) Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/eurofins/genevoyager-2

CategoryEurofins Central LaboratoryGenevoyager (Wuhan) Co., Ltd.
Listed sitebothboth
SummaryGlobal network of over 950 laboratories across 57 countries offering comprehensive contract research, testing, and manufacturing services including BioPharma discovery, bioanalysis, Phase I clinics, CDMO, central laboratory services, and specialized analytical testing.Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.
Services
  • Central Laboratory Services
  • Phase I Clinical Trials
  • Bioanalysis
  • Genomics & Sequencing Services
  • Translational Research
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
ModalitiesData not yet provided.
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
CertificationsData not yet provided.
  • China · Identifier: High-tech Enterprise (高新技术企业)
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.